Alzheimer’s

Politics David Nather

How a crash course in public health could lead to a big boost in NIH funding

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Valeant feels attacked, Alzheimer’s risk with prostate cancer drug

Business David Nather

Mark Zuckerberg dedicates huge chunk of his fortune to curing diseases

Pharmalot Ed Silverman

Allergan and New York settle suit over Alzheimer’s drug switching

Pharmalot Ed Silverman

Bill for speeding drug approvals would have been costly for Alzheimer’s

Business Robert Weisman — Boston Globe

Biogen making risky shift from MS to Alzheimer’s

In the Lab Leah Samuel

When nerds hit the red carpet: ‘I had a nightmare it would be a colossal joke’

Pharmalot Ed Silverman

Supreme Court asked to weigh pharma tactics limiting consumer choice

Gut Check Sharon Begley

Watch: Top Alzheimer’s approach makes (mice) brains worse

In the Lab Stephanie Simon

Unlocking secrets of the brain pays off with Breakthrough Prize

Health Megan Thielking

‘Dementia-friendly’ communities take root across US